RESEARCH ARTICLE
Nobel Med 2009; 5(3): 65-69
DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan AydoğduABSTRACT
Material and Methods:Ninetyfive patients were evaluated with coronary angiography initially H. pylori were tested by using urea breath test in 72 CAD patients. Difference were not significant as a statistically. H. pylori eradication therapy was applied to 30 patients with H. pylori infection for 14 days and 22 patients with H. pylori infection were not given eradication therapy. Lipid profile and high sensitive C-reactive protein levels were measured and compared in both eradicated and non-eradicated groups before and two months after the H. pylori eradication.
Results: Seventytwo patients had CAD and 23 patients were normal as an angiographically. Fifty two CAD (72%) patients and 15 non-CAD (65%) patients had H.pylori infection and the difference was statistically not significant. Total cholesterol, LDL-cholesterol and hs-CRP were significantly decreased in H. pylori eradication achieved group (n=25) compared to non-eradication group (n=22). However, changes in HDL-cholesterol and trigliserid levels were not significant statistically.
Conclusion: Eradication of H. pylori in patients with CAD decrease total cholesterol , LDL-cholesterol and high sensitive C-reactive protein levels. This may help to slow down the atherosclerotic process indirectly in these patients.
VESTIBÜLER SISTEM ANATOMI, FIZYOLOJISI VE BOZUKLUKLARI
05-08Caner Şahin
REVIEW Nobel Med 2009; 5(3): 05-08BONE MYOREGULATION REFLEX: A POSSIBLE NEW MECHANISM
09-17İlhan Karacan, Mustafa Akif Sarıyıldız, Önder Ergin, Aynur Özen, Safak Sahir Karamehmetoğlu
RESEARCH ARTICLE Nobel Med 2009; 5(3): 09-17KNOWLEDGE AND UTILIZATION OF HEALTH SERVICES OF PEOPLE APPLYING TO A HEALTH CENTER IN UMRANIYE
18-26Seyhan Hıdıroğlu, M. Fatih Önsüz, Serdar Sülün, Ahmet Topuzoğlu, Melda Karavuş
RESEARCH ARTICLE Nobel Med 2009; 5(3): 18-26AN ASSESSMENT OF AWARENESS AND SELF-REPORT ABOUT OCCUPATION-RELATED HEALTH PROBLEMS AMONG DENTAL LABORATORY TECHNICIANS IN TURKEY
27-32Gülcan Coşkun Akar, Gökhan Aksoy, Nezih Metin Özmutaf, Harun Akar
RESEARCH ARTICLE Nobel Med 2009; 5(3): 27-32MISSED CHRONIC DISEASE PREVENTION OPPORTUNITIES IN PRIMARY HEALTH CARE CLINICS IN TURKEY
33-39Kazım Tırpan, Ahmet Topuzoğlu, Asya Banu Topuzoğlu
RESEARCH ARTICLE Nobel Med 2009; 5(3): 33-39VASCULAR ENDOTHELIAL GROWTH FACTOR FOR DIFFERENTIAL DIAGONSIS OF NONMALIGNANT PLEURAL EFFUSIONS
40-44Dilaver Taş, Oğuzhan Okutan, Tayfun Çalışkan, Osman Metin İpçioğlu, Faruk Çiftçi, Zafer Kartaloğlu
RESEARCH ARTICLE Nobel Med 2009; 5(3): 40-44PHYSICIANS’ POINT OF VIEW TO CLINICAL PHARMACY AS EFFECTIVE HUMAN RESOURCE
45-52Özlem Nazan Erdoğan, Esin Karacan
RESEARCH ARTICLE Nobel Med 2009; 5(3): 45-52A STUDY OF THE FACTORS AFFECTING THE DURATION OF EXCLUSIVE BREASTFEEDING
53-57Hayriye Ertem Vehid, Durata Haciu, Suphi Vehid, Gülbin Gökçay, Ayşen Bulut
RESEARCH ARTICLE Nobel Med 2009; 5(3): 53-57AORTIC ELASTIC PROPERTIES, CAROTID INTIMA-MEDIA THICKNESS AND CORONARY FLOW RESERVE IN PATIENTS WITH PERIPHERAL ARTERY DISEASE
58-64Hüseyin Oflaz, Ali Elitok, Arif Çimen, Burak Pamukçu, Mustafa Tükenmez, İmran Onur, Ebru Gölcük, Erdem Kaşıkçıoğlu, Ramazan Kurt, Mustafa Demirtürk, Murat Aksoy
RESEARCH ARTICLE Nobel Med 2009; 5(3): 58-64DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE
65-69Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu
RESEARCH ARTICLE Nobel Med 2009; 5(3): 65-69THE EFFECT OF PRENATAL FACTORS ON THE DEVELOPMENT OF RECTAL CANCER
70-73Feyyaz Özdemir, Ahmet Beşir, Kerem Ersoy, Evren Fidan, Bülent Yıldız, Halil Kavgacı, Fazıl Aydın
RESEARCH ARTICLE Nobel Med 2009; 5(3): 70-73RISK FACTORS AND MANNHEIM PERITONITIS INDEX FOR THE PREDICTION OF MORBIDITY AND MORTALITY IN PATIENTS WITH PEPTIC ULCER PERFORATION
74-81Mehmet Yıldırım, Ömer Engin, Enver İlhan, Ali Coşkun
RESEARCH ARTICLE Nobel Med 2009; 5(3): 74-81AN OVERVIEW OF THE OUTCOMES OF THE SOCIAL COOPERATION PROJECT IMPLEMENTED FOR THE WORST FORMS OF CHILD LABOR IN ADANA PROVINCE OF TURKEY
82-87Ferdi Tanır
RESEARCH ARTICLE Nobel Med 2009; 5(3): 82-87WORK RELATED ASTHMA IN GARBAGE COLLETORS
88-94Mustafa Erelel, Halim İşsever, Recep Yılmaz Bayraktarlı, Özkan Ayvaz, Günay Yılmaz Güngör, Suna ErbilKürşat Özdilli, H.Hüseyin Eker
RESEARCH ARTICLE Nobel Med 2009; 5(3): 88-94IATROGENIC CUSHING’S SYNDROME ADHERED TO POMADES WITH TOPICAL STEROID
95-98Avni Kaya, Sevil Arı Yuca, Murat Doğan, Ertan Sal, Hayrettin Temel, Yaşar Cesur
REPORT Nobel Med 2009; 5(3): 95-98ANOMALOUS ORIGIN OF CORONARY ARTERY AND MITRAL VALVE PROLAPSE
99-101Mehmet DEMİR
REPORT Nobel Med 2009; 5(3): 99-101PROF. DR. MÜFIDE KÜLEY
102-107Arın Namal, Öztan Öncel
A PORTRAIT Nobel Med 2009; 5(3): 102-107LIVER AND SYSTEMIC DISEASES
05-09Sebati Özdemir
REVIEW Nobel Med 2013; 9(2): 5-9AGING KIDNEY: SENESCENCE OR DISEASE?
10-14Meltem Gürsu, Rümeyza Kazancıoğlu, Savaş Öztürk
REVIEW Nobel Med 2013; 9(2): 10-14IMPORTANCE OF HOLOTRANSCOBALAMIN (HOLOTC) MEASUREMENTS IN EARLY DIAGNOSIS OF COBALAMIN DEFICIENCY, ESPECIALLY IN PATIENTS WITH BORDERLINE VITAMIN B12 CONCENTRATIONS
15-20Faruk Sönmezışık, Esma Sürmen Gür, Burak Asıltaş
RESEARCH ARTICLE Nobel Med 2013; 9(2): 15-20EVALUATION OF PHYSICAL GROWTH IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER
21-25Celalettin Koşan, Oğuzhan Sepetçigil, Atilla Çayır, Avni Kaya, Behzat Özkan
RESEARCH ARTICLE Nobel Med 2013; 9(2): 21-25COMPARISON OF RISK INDEXES USED IN DETERMINING THE POSTOPERATIVE RESPIRATORY INSUFFICIENCY RISK
26-31Gülsüm Kavalcı, Cavidan Arar, Alkın Çolak, Nesrin Turan, Cemil Kavalcı
RESEARCH ARTICLE Nobel Med 2013; 9(2): 26-31THE EVALUATION OF PRENATAL AND ENVIROMENTAL RISK FACTORS IN CHILDREN WITH ASTHMA, ALLERGIC RHINITIS AND BRONCHIAL ASTHMA ABSTRACT
32-37Mehmet İbrahim Turan, Müferet Ergüven, Mehmet Özdemir
RESEARCH ARTICLE Nobel Med 2013; 9(2): 32-37REOPERATIONS AND MORBIDITY IN THYROID SURGERY
38-42Serkan Teksöz, Murat Özcan, Aytül Sargan, Yusuf Bukey, Recep Özgültekin, Ateş Özyeğin
RESEARCH ARTICLE Nobel Med 2013; 9(2): 38-42EFFECTS OF RAMADAN FASTING ON BLOOD PRESSURE CONTROL, LIPID PROFILE, BRAIN NATRIURETIC PEPTIDE, RENAL FUNCTIONS AND ELECTROLYTE LEVELS IN HYPERTENSIVE PATIENTS TAKING COMBINATION THERAPY
43-46İbrahim Faruk Aktürk, İsmail Bıyık, Cüneyt Koşaş, Ahmet Arif Yalçın, Mehmet Ertürk, Fatih Uzun
RESEARCH ARTICLE Nobel Med 2013; 9(2): 43-46MANAGEMENT OF A LARGE OUTBREAK CAUSED BY NOROVIRUS AND CAMPYLOBACTER JEJUNI OCCURRED IN A RURAL AREA IN TURKEY
47-51İbak Gönen
RESEARCH ARTICLE Nobel Med 2013; 9(2): 47-51FREQUENT CD99 AND FLI-1 EXPRESSIONS IN DIFFUSE LARGE B-CELL LYMPHOMA AND THEIR ASSOCIATION WITH PROLIFERATIVE AND APOPTOTIC RATES
52-56Ufuk Berber, İsmail Yılmaz, Tolga Tuncel, Zafer Küçükodacı Aptullah Haholu
RESEARCH ARTICLE Nobel Med 2013; 9(2): 52-56-
Pubmed Style
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu. [DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE]. Nobel Med 2009; 5(3): 65-69, English. -
Web Style
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu. [DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE]. www.nobelmedicus.com/en/Article.aspx?m=1716 [Access: Mayıs 24, 2021], English. -
AMA (American Medical Association) Style
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu. [DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE]. Nobel Med 2009; 5(3): 65-69, English. -
Vancouver/ICMJE Style
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu. [DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE]. Nobel Med (2009); 5(3): 65-69, [cited Mayıs 24, 2021], English. -
Harvard Style
Yasar Küçükardalı, Şebnem Aydoğdu, Selim Nalbant, Emrullah Solmazgül, Namık Özmen, Muammer Urhan, Mustafa Özyurt, Aydoğan Aydoğdu. (2009) [DOES HELICOBACTER PYLORI ERADICATION IMPROVE INFLAMMATION AND LIPID PROFILE IN PATIENTS WITH CORONARY ARTERY DISEASE]. Nobel Med, 5(3): 65-69, English.